Today's Big Stories

ARVs soon to be available to all HIV patients, irrespective of CD4 count

Health Minister Aaron Motsoaledi has announced that all HIV-positive South Africans will have access to anti-retroviral drugs (ARVs) by September this year.

The CD4 eligibility criterion for ARV medication will be removed from healthcare policies after clinical evidence showed the benefits of early treatment.

Leading HIV scientist Professor Salim Abdool Karim says that early treatment will reduce the chances of contracting an infectious disease or developing an AIDS-related illness.

We now know that these patients will do better. They will have fewer episodes of TB, fewer events relating to HIV such as pneumonia or meningitis, and they will have a close to normal life span.

Professor Salim Abdool Karim, Director for the Centre for Aids Program of Research in South Africa

In addition, early treatment may provide preventative benefits as the ARVs decrease a patient's level of infectiousness.

Listen to the full conversation from The Midday Report:


Recommended

by NEWSROOM AI
Read More
New calls for medical aid schemes to pay for HIV prevention drugs

New calls for medical aid schemes to pay for HIV prevention drugs

Medical aid companies stand to benefit from preventative HIV care packages for clients, says healthcare funder Dr Humphrey Zokufa.

Drugs will reduce risk of getting HIV - Health department on board

Drugs will reduce risk of getting HIV - Health department on board

The use of ARV's as a pre-exposure drug has proved highly effective in reducing the risk of people contracting HIV.

Male sexual health and the new HIV preventive drug explained

Male sexual health and the new HIV preventive drug explained

Dr Shingai Mutambirwa tackles listeners' questions on male sexual health and talks about Truvada, the new HIV preventive drug.

Medicines Control Council approves HIV prevention drug

Medicines Control Council approves HIV prevention drug

In a ground-breaking development, South Africans will have access to Truvada, a new drug that will reduce their chances of HIV infection.

'We need to refocus on prevention of HIV infections' - Prof Helen Rees

'We need to refocus on prevention of HIV infections' - Prof Helen Rees

The Wits Reproductive Health and HIV Institute's Professor Helen Rees says we need to refocus on prevention of HIV infections.

Fewer deaths in SA than any time since 2001 (and 4 other insights from Stats SA)

Fewer deaths in SA than any time since 2001 (and 4 other insights from Stats SA)

Flu kills more South Africans of all ages than HIV. This and other surprising insights from Stats SA’s latest mortality report.

Popular articles
CR17: 'Face the nation! Tell us what happened! End this PR disaster'

CR17: 'Face the nation! Tell us what happened! End this PR disaster'

There was nothing illegal, yet the CR17 leaks is a PR disaster for Cyril Ramaphosa, says communications consultant Chris Vick.

Trevor Noah – 4th highest paid comedian on Earth – made R430 million in 2018

Trevor Noah – 4th highest paid comedian on Earth – made R430 million in 2018

Trevor Noah cracked Forbes magazine’s list of highest-paid stand-up comedians in the world.

Want to get rich? Got R100? You don’t need millions to start

Want to get rich? Got R100? You don’t need millions to start

Bruce Whitfield interviews Anthea Gardner, author of "Make Your Money Work for You: Think Big, Start Small".

SA’s richest woman opens up about being a refugee and becoming a billionaire

SA’s richest woman opens up about being a refugee and becoming a billionaire

Magda Wierzycka – Sygnia’s renegade CEO – on her attitude toward money (hopes and fears, successes and failures, etc.).

Former EFF MP: 'I didn't know where the money came from until it was leaked'

Former EFF MP: 'I didn't know where the money came from until it was leaked'

EFF member Tebogo Mokwele and Small Business Development Minister Khumbudzo Ntshavheni respond to leaked CR17 bank statements.

Benguela Global Fund Managers is buying Naspers, Standard Bank and Pick n Pay

Benguela Global Fund Managers is buying Naspers, Standard Bank and Pick n Pay

Zwelakhe Mnguni (CIO at Benguela Global Fund Managers) shares his stock picks of the week: Naspers, Standard Bank and Pick n Pay.

'Debt relief law may cause banks to stop lending to lower-income clients'

'Debt relief law may cause banks to stop lending to lower-income clients'

The Money Show’s Bruce Whitfield interviews Cas Coovadia, Managing Director at the Banking Association of South Africa.

[WATCH] Father and daughter dance-off changes tune when she starts twerking

[WATCH] Father and daughter dance-off changes tune when she starts twerking

Khabazela shares tweets and Facebook posts that have gone viral.